1249701

Jeffrey M. Kaplan, M.D. — FEI 3031659517

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 20, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Overland Park, KS (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
736321 CFR 50.55(f)Documentation of permission by parents or guardian
736721 CFR 50.55(e)(2)Two parents' permission: studies under Parts 50.53 - 50.54
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance